Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach

被引：1

作者：

Ceresoli, Giovanni Luca

Rossi, Giulio ^{[1
]}

Agustoni, Francesco ^{[2
,3
]}

Bonomi, Lucia ^{[4
]}

Borghetti, Paolo ^{[5
]}

Bulotta, Alessandra ^{[6
]}

Casartelli, Clelia ^{[7
]}

Cerea, Giulio ^{[8
]}

Colonese, Francesca ^{[9
]}

del Signore, Ester ^{[10
,11
]}

Finocchiaro, Giovanna ^{[12
]}

Gianoncelli, Letizia ^{[13
]}

Grisanti, Salvatore ^{[14
]}

Maiolani, Martina ^{[15
]}

Pagni, Fabio ^{[16
]}

Proto, Claudia ^{[17
]}

Rijavec, Erika ^{[18
]}

Vittimberga, Isabella ^{[19
]}

Arcangeli, Stefano ^{[20
]}

Filippi, Andrea Riccardo ^{[21
,22
]}

机构：

[1] Human Gavazzeni Hosp, Dept Med Oncol, Bergamo, Italy

[2] Hosp Inst Fdn Poliambulanza, Pathol Unit, Via Bissolati 57, I-25124 Brescia, Italy

[3] Univ Pavia, Dept Internal Med & Med Therapy, Pavia, Italy

[4] Fdn IRCCS Policlin San Matteo, Med Oncol Unit, Pavia, Italy

[5] ASST Papa Giovanni XXIII Hosp, Unit Oncol, Bergamo, Italy

[6] ASST Spedali Civili & Univ Brescia, Radiat Oncol Dept, Brescia, Italy

[7] IRCCS San Raffaele, Dept Oncol, via Olgettina 60, Milan, Italy

[8] Valduce Hosp, Unit Oncol, Como, Italy

[9] ASST Grande Osped Metropolitano Niguarda, Niguarda Canc Ctr, Milan, Italy

[10] ASST San Gerardo Monza, Med Oncol Unit, Monza, Italy

[11] European Inst Oncol, Div Thorac Oncol, IEO, Milan, Italy

[12] IRCCS, Ist Clin Human, Human Canc Ctr, Med Oncol & Hematol Unit, Rozzano, Italy

[13] San Paolo Hosp, Med Oncol Unit, ASST Santi Paolo & Carlo, Milan, Italy

[14] Univ Brescia, ASST Spedali Civili Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Med Oncol Unit, Brescia, Italy

[15] UOC Oncol Med ASST Valtellina & Alto Lario, Sondrio, Italy

[16] Univ Milano Bicocca, Dept Med & Surg, Pathol, Via Cadore 48, I-20900 Monza, Italy

[17] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy

[18] ASST Sette Laghi, Osped Circolo & Fdn Macchi, Unit Med Oncol, Varese, Italy

[19] Osped A Manzoni, Oncol Dept, Lecce, Italy

[20] Univ Milano Bicocca, Dept Radiat Oncol, Milan, Italy

[21] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy

[22] Fdn IRCCS Policlin San Matteo, Radiat Oncol, Pavia, Italy

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2024年 / 199卷

关键词：

Small-cell lung cancer; SCLC; Immunotherapy; Patient management; PLUS PLATINUM-ETOPOSIDE; ES-SCLC; ATEZOLIZUMAB ATZ; PD-L1; EXPRESSION; CARBOPLATIN CB; PHASE IIIB; OPEN-LABEL; SURVIVAL; DURVALUMAB; SUBTYPES;

D O I：

10.1016/j.critrevonc.2023.104247

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Immunotherapy represented a turning point for treating extensive small-cell lung cancer (ES-SCLC). Although, many issues remain debated. Methods: A group of Italian medical and radiation oncologists with expertise in managing patients with ES-SCLC developed a list of statements divided in six areas of interest. The Delphi method was used to assess the consensus on the defined list of statements. Results: 32 statements were included in the final list to be voted by the Delphi panel, and 26 reached a consensus on the agreement. A prompt involvement of a multidisciplinary team is a priority to provide an integrated treatment strategy. First-line recommended treatment is immunotherapy in combination with platinum-based chemotherapy and etoposide for four cycles followed by maintenance immunotherapy. Conclusions: While awaiting new data from clinical trials and real-world studies, these recommendations can represent a useful tool to guide the management of ES-SCLC patients in daily practice.

引用

页数：9

共 50 条

[31] Immunotherapy for small-cell lung cancer: emerging evidence
Reck, Martin
Heigener, David
Reinmuth, Niels
FUTURE ONCOLOGY, 2016, 12 (07) : 931 - 943
[32] A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer
Shibayama, Takuo
Hotta, Katsuyuki
Takigawa, Nagio
Tada, Atsuhiko
Ueoka, Hiroshi
Harita, Shingo
Kiura, Katsuyuki
Tabata, Masahiro
Segawa, Yoshihiko
Nogami, Naoyuki
Kuyama, Shoichi
Shinkai, Tetsu
Tanimoto, Mitsune
LUNG CANCER, 2006, 53 (02) : 189 - 195
[33] Extensive-stage small-cell lung cancer: Current management and future directions
Yu, Ying
Chen, Kaiyan
Fan, Yun
INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (11) : 2243 - 2256
[34] What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?
Nesbit, Eric G.
Leal, Ticiana A.
Kruser, Tim J.
TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S153 - S162
[35] Survival evaluation in patients with extensive small cell lung cancer treated with immunotherapy
Frebutte, Elise
Descamps, Olivier
Gilbert, Marie
de Lovinfosse, Solange
ACTA CLINICA BELGICA, 2021, 76 : 52 - 52
[36] CARBOPLATIN AND ETOPOSIDE IN EXTENSIVE SMALL-CELL LUNG-CANCER
VIREN, M
LIIPPO, K
OJALA, A
HELLE, L
HINKKA, S
HUOVINEN, R
JAKOBSSON, M
JARVINEN, M
PALOHEIMO, S
SALMI, R
SALOMAA, ER
NIKKANEN, V
ACTA ONCOLOGICA, 1994, 33 (08) : 921 - 924
[37] PALLIATIVE THERAPY - EXTENSIVE SMALL-CELL LUNG-CANCER
LOEHRER, PJ
SEMINARS IN ONCOLOGY, 1995, 22 (02) : 40 - 44
[38] Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer
Schild, Steven E.
Sio, Terence T.
Daniels, Thomas B.
Chun, Stephen G.
Rades, Dirk
JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (11) : 732 - +
[39] Prophylactic cranial irradiation in extensive small-cell lung cancer
Slotman, Ben
Faivre-Finn, Corinne
Kramer, Gijs
Rankin, Elaine
Snee, Michael
Hatton, Matthew
Postmus, Pieter
Collette, Laurence
Musat, Elena
Senan, Suresh
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (07): : 664 - 672
[40] Combination of bevacizumab and dual immunotherapy for extensive-disease small-cell lung cancer: a case report
Song, Lei
Zhou, Rengui
Li, Xiangyong
Pan, Dejian
IMMUNOTHERAPY, 2021, 13 (16) : 1309 - 1315

← 1 2 3 4 5 →